20
Cat No. | Product Name | Synonyms | Targets |
---|---|---|---|
T5S2129 | Sciadopitysin | TNF , NF-κB | |
Sciadopitysin may prevent the development of diabetic osteopathy, it exerts its therapeutic effects via upregulation of mitochondrial biogenesis.Sciadopitysin shows protective effects on antimycin A-induced toxicity in o... | |||
T1973 | PFI-4 | PFI4 | Epigenetic Reader Domain |
PFI-4 is a potent and selective and cell-permeable BRPF1 bromodomain inhibitor. | |||
T7736 | 2-Chloroadenosine | Adenosine Receptor | |
2-Chloroadenosine (CADO) is a metabolically stable analog of adenosine that binds to adenosine A1, A2A, and A3 receptors( Ki:300, 80, and 1,900 nM, respectively) | |||
T1287 | Synephrine | Oxedrine | Endogenous Metabolite , Adrenergic Receptor |
Synephrine (Oxedrine) is sympathetic alpha-adrenergic agonist used as a vasoconstrictor in circulatory failure, asthma, nasal congestion, and glaucoma. | |||
T5575 | Cycloastragenol | Cyclogalegenol,Astramembrangenin | Epigenetic Reader Domain , Telomerase |
Astramembrangenin (Cycloastragenol (Astramembrangenin)) is a triterpenoid saponin compound and a hydrolysis product of the main active ingredient in Astragalus membranaceus. Cycloastragenol (CAG) may have a novel therape... | |||
T21616 | L-006235 | L 006235 | Cysteine Protease |
L-006235 is a potent and reversible inhibitor of cathepsin K with IC50 of 0.25 nM. | |||
T1867 | Otenaproxesul | ATB 346 | Apoptosis , COX |
Otenaproxesul (ATB 346) is a novel hydrogen sulphide-releasing derivative of naproxen with markedly reduced toxicity. | |||
T7683 | Adenosine amine congener | ADAC | Adenosine Receptor |
Adenosine amine congener (ADAC) (ADAC) is an agonist of selective A1 adenosine receptor,. | |||
TN1494 | Cimicifugoside H-1 | Others | |
Cimicifugoside H1 shows the protective function to cerebral neuron during cerebral ischemia. | |||
T1812 | KX1-004 | KX1 004,KX1004 | Src |
KX1-004, a potential protective drug for NIHL, is an effective small molecule inhibitor of Src-PTK. | |||
T8528 | AC1903 | TRP/TRPV Channel | |
AC1903 is a specific inhibitor of TRPC5 channel, and has been shown to suppress severe proteinuria and prevent podocyte loss. | |||
T11394 | GFB-8438 | TRP/TRPV Channel | |
GFB-8438 is a potent and subtype selective inhibitor of TRPC5(IC50s of 0.18 and 0.29 μM of hTRPC5 and hTRPC4, respectively). | |||
T6688 | Synephrine hydrochloride | Oxedrine hydrochloride,Synephrine HCl | Endogenous Metabolite , Adrenergic Receptor |
Synephrine hydrochloride (Oxedrine hydrochloride) is an agonist that acts on sympathomimetic α-adrenergic receptor (AR). | |||
T4110 | Perivine | Perivin | Others |
Perivine (Perivin) may resolve the instability of the retinoblastoma-associated proteins (RbAp48) complex and thus be used in Alzheimer's disease therapy. Perivine, vobasine, coronaridine and dichomine show hypotensive a... | |||
T1952 | MK-2206 dihydrochloride | MK-2206 2HCl | Apoptosis , Akt , Autophagy |
MK-2206 dihydrochloride (MK-2206 2HCl) is a variant Akt inhibitor that inhibits Akt1, Akt2, and Akt3 (IC50=8/12/65 nM) with orally active, highly potent and selective potency. MK-2206 dihydrochloride exhibits antitumor a... | |||
T126237 | Cynoglossamine | ||
Cynoglossamine is a useful organic compound for research related to life sciences and the catalog number is T126237. | |||
TN5834 | Loroglossin | ||
Loroglossin is a natural product for research related to life sciences. The catalog number is TN5834 and the CAS number is 58139-22-3. | |||
T28232 | Oleoylestrone | Estrone 3-oleate,MP 101,MP-101,MP101 | Antioxidant |
Oleoylestrone (MP-101) is present in plasma and adipose tissue, has potential antioxidant effects, induces loss of body fat in rats, and can be used for weight loss. | |||
T6572 | Lorcaserin HCl | 5-HT Receptor | |
Lorcaserin is a selective serotonin agonist that has been recently approved as a weight loss agent. | |||
T15014 | CTPB | Histone Acetyltransferase | |
CTPB is a potent p300 histone acetyltransferase (HAT) activator that can be used in the preparation of hair growth promoters and/or hair loss treatments. |